Drug Trial Radar · NCT07339748
A Clinical Study of ZL-85FA Tablets
Last checked: Nov 19, 2026Latest source record: Jan 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
51
Planned (sponsor's estimate)
Start
Jun 30, 2026
Primary completion
Jun 30, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Chengdu Zenitar Biomedical Technology Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jan 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors
Conditions
- Advanced Solid Tumor
Interventions
ZL-85FA tabletsDrug
ZL-85FA tablets 2.5mg, oral, once daily
ZL-85FA tabletsDrug
ZL-85FA tablets 5mg, oral, once daily
ZL-85FA tabletsDrug
ZL-85FA tablets 10mg, oral, once daily
ZL-85FA tabletsDrug
ZL-85FA tablets 15mg, oral, once daily
ZL-85FA tabletsDrug
ZL-85FA tablets 20mg, oral, once daily
ZL-85FA tabletsDrug
ZL-85FA tablets 25mg, oral, once daily
ZL-85FA tabletsDrug
ZL-85FA tablets 30mg, oral, once daily
ZL-85FA tabletsDrug
Based on the results obtained from the dose escalation phase, the necessity and dosage of the IIa phase expansion cohort will be determined by the Drug Safety Review Committee (SMC) after discussion.
ZL-85FA tabletsDrug
Based on the results obtained from the dose escalation phase, the necessity and dosage of the IIa phase expansion cohort will be determined by the Drug Safety Review Committee (SMC) after discussion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective remission rateTime frame: Up to week 96
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital Of Anhui Medical University
Hefei, Anhui, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.